Reviticell Holdings, Inc. Email Format
Biotechnology ResearchFlorida, United States2-10 Employees
Reviticell operates in biotechnology research and has developed the Reviticell System, a device designed to streamline the preparation of regenerative medicine treatments. The system is intended to perform, in a clinical setting, what would otherwise require a laboratory setup and dedicated staff, by using a sequence of modular cartridges that contain the components needed to prepare a specific treatment under a proprietary protocol. This arrangement aims to deliver more consistent and efficient outcomes and reduces the complexity often associated with preparing therapies during procedures. The field it serves, regenerative medicine, is a substantial and growing market. Based in Jacksonville, Florida, the company is described as a small team within the biotechnology research space. Its target customers are physicians practicing regenerative medicine who must prepare patient-specific treatments during procedures, addressing the challenges of in-room preparation and associated risks. By offering a standardized cartridge-based workflow, the Reviticell System provides a way to produce regenerative treatments with greater consistency and efficiency.